Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.47 |
| ▸ | PDE4A | P27815 | 1/20 | 0.41 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 4/20 | 0.39 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.34 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.34 |
| ▸ | ENPEP | Q07075 | 3/20 | 0.34 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.33 |
| ▸ | GABRP | O00591 | 1/20 | 0.33 |
| ▸ | GABRD | O14764 | 1/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.33 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glutarate SCHEMBL17748589 | 1.00 | USP2 (0.47) | USP2SLCO1B1PDE4APAX8LMNA | |
| Adipic Acid SCHEMBL17748607 | 0.97 | USP2 (0.47) | USP2SLCO1B1PDE4APAX8LMNA | |
| Azelaic Acid SCHEMBL5981826 | 0.95 | USP2 (0.46) | USP2SLCO1B1PDE4APAX8LMNA | |
| Succinic Acid SCHEMBL722957 | 0.93 | USP2 (0.50) | USP2SLCO1B1PDE4APAX8LMNA | |
| Succinic Acid SCHEMBL17748517 | 0.93 | USP2 (0.50) | USP2SLCO1B1PDE4APAX8LMNA | |
| Palmitic Acid SCHEMBL2775373 | 0.88 | GPR84 (0.49) | USP2PDE4ALMNASLC22A6TDP1 | |
| Bicarbonate SCHEMBL20888 | 0.87 | USP2 (0.55) | USP2SLCO1B1PDE4APAX8LMNA | |
| Malonic Acid SCHEMBL17748563 | 0.86 | USP2 (0.50) | USP2SLCO1B1PDE4APAX8LMNA | |
| Glycine SCHEMBL2842691 | 0.86 | USP2 (0.50) | USP2SLCO1B1PDE4APAX8LMNA | |
| Malonic Acid SCHEMBL5866696 | 0.86 | USP2 (0.50) | USP2SLCO1B1PDE4APAX8LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9585988-B2 | Anchorage devices comprising an active pharmaceutical ingredient | TYRX, INC. (US) | 2017-03-07 | — | — | US | claimed |
| US-12447242-B2 | Hemostatic devices and methods of use | MEDTRONIC, INC. (US) | 2025-10-21 | — | — | US | disclosed |
| EP-3452124-B1 | HEMOSTATIC DEVICES AND METHODS OF USE | MEDTRONIC INC (US) | 2025-10-08 | — | — | EP | disclosed |
| EP-3452123-B1 | HEMOSTATIC DEVICES AND METHODS OF USE | MEDTRONIC INC (US) | 2025-09-24 | — | — | EP | disclosed |
| EP-3452126-B1 | HEMOSTATIC DEVICES AND METHODS OF USE | MEDTRONIC INC (US) | 2025-08-27 | — | — | EP | disclosed |
| US-20250262358-A1 | SURGICAL SYSTEM AND METHODS OF USE | MEDTRONIC INC (US) | 2025-08-21 | — | — | US | disclosed |
| EP-3452125-B1 | CUSTOMIZABLE ANCHORAGE DEVICES AND METHODS OF USE | MEDTRONIC INC (US) | 2025-07-16 | — | — | EP | disclosed |
| US-20250152332-A1 | SURGICAL SYSTEM AND METHODS OF USE | MEDTRONIC, INC. | 2025-05-15 | — | — | US | disclosed |
| US-12168086-B2 | Hemostatic devices and methods of use | MEDTRONIC, INC (US) | 2024-12-17 | — | — | US | disclosed |
| US-12168085-B2 | Surgical system and methods of use | MEDTRONIC, INC (US) | 2024-12-17 | — | — | US | disclosed |
| EP-2079387-A1 | MESH POUCHES FOR IMPLANTABLE MEDICAL DEVICES | TYRX PHARMA INC. (US) | 2009-07-22 | — | — | EP | disclosed |
| US-20090088548-A1 | Resorbable Phenolic Polymers | TYRX PHARMA, INC. (US) | 2009-04-02 | — | — | US | disclosed |
| US-20090018559-A1 | Temporarily Stiffened Mesh Prostheses | TYRX PHARMA, INC. (US) | 2009-01-15 | — | — | US | disclosed |
| WO-2008136856-A2 | RESORBABLE POUCHES FOR IMPLANTABLE MEDICAL DEVICES | TYRX PHARMA, INC. (US) | 2008-11-13 | — | — | WO | disclosed |
| WO-2008127411-A1 | MESH POUCHES FOR IMPLANTABLE MEDICAL DEVICES | TYRX PHARMA, INC. (US) | 2008-10-23 | — | — | WO | disclosed |
| WO-2008121816-A2 | BIODEGRADABLE, POLYMER COVERINGS FOR BREAST IMPLANTS | TYRX PHARMA, INC. (US) | 2008-10-09 | — | — | WO | disclosed |
| US-20080241212-A1 | Tyrosine-derived aromatic polyester sheet, film or mat of nanofibers optionally including anesthetics, antiinflammatories, microbiocides, leukotriene inhibitors, or antiscarring, antifibrotic, or antineoplastic agents, and that resists capsular contracture and adherence to the implant | TYRX PHARMA, INC. (US) | 2008-10-02 | — | — | US | disclosed |
| US-20080132922-A1 | Mesh Pouches for Implantable Medical Devices | TYRX PHARMA, INC. (US) | 2008-06-05 | — | — | US | disclosed |
| US-20080128315-A1 | Biodegradable polylactic acid polymer pouches for pacemaker, defibrillator, pulse generator cardiac rhythm mamagent devices; antimicrobial agents, anesthetics, anti-inflammatory agents, anti-scarring drugs in polymer matrix; barrier to microbial colonization of medical device during surgical implantation | TYRX PHARMA, INC. (US) | 2008-06-05 | — | — | US | disclosed |
| US-20070198040-A1 | Temporarily Stiffened Mesh Prostheses | TYRX PHARMA INC. (US) | 2007-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090088548-A1 | Resorbable Phenolic Polymers | PAH, PUF60, MKI67 | USP2 2276/4885SLCO1B1 1907/4885PDE4A 3644/4885 |
| US-12168086-B2 | Hemostatic devices and methods of use | PLAT, HABP2, F2 | USP2 725/4885SLCO1B1 4876/4885PDE4A 2991/4885 |
| US-12168085-B2 | Surgical system and methods of use | FGB, F2, COL14A1 | USP2 1094/4885SLCO1B1 4844/4885PDE4A 2854/4885 |
| US-12447242-B2 | Hemostatic devices and methods of use | HABP2, PLAT, F2 | USP2 506/4885SLCO1B1 4878/4885PDE4A 2974/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.